Fidelity International Strategic Ventures

FISV leverages Fidelity International's global distribution relationships, institutional client networks, and internal-sector research teams to surface opportunities. The group also operates Fidelity Labs, an internal incubator whose output can generate commercial dialogues with external startups. This hybrid model—external venture investing paired with internal product incubation—gives the team early visibility into emerging technology categories.

FISV's publicly disclosed activity shows only direct minority equity investments in operating companies. There is no public record of the group committing as a limited partner to external venture capital funds. The strategic rationale—building direct relationships with founders and technology platforms—favors principal investing over fund-of-funds exposure.

FISV targets Series A and later-stage rounds where the business model has been at least partially de-risked. The group does not market itself as a seed-stage investor. Confirmed portfolio companies such as Wombat and Currencycloud had established revenue lines and regulatory footing when FISV entered their capitalization tables.

The group does not publish an explicit exclusion list. However, FISV's disclosed portfolio concentrates narrowly on financial technology, wealth technology, and insurance technology. There is no public evidence of the group pursuing industrial-technology, deep-science, or hard-asset infrastructure plays outside the financial-services envelope.

FISV and Fidelity Labs sit under the same Fidelity International innovation umbrella but serve different purposes. FISV takes minority equity stakes in external companies, while Fidelity Labs builds and tests proprietary digital products internally. Some Labs prototypes can influence FISV's investment thesis in a category, but the two arms operate with separate leaders and capital pools.